Member Login
|
New USER
Advocacy
State Advocacy
Federal Advocacy
>
Letters
FHA Political Committee
Health Care Issues
Behavioral Health
Workforce
>
Workforce Resources
Patients Awaiting Discharge to Post-Acute Care Settings
Emergency Management
Accreditation
Compliance/HIPAA
Hospital Finances
Quality & Safety
Education & Events
Annual Meeting
Hospital Days
Calendar
Popular Education Series
>
Novice Infection Prevention Series
Statewide Readmissions Prevention Series
Sponsor Opportunities
Reports & Resources
Economic Impact
Facts and Stats
Florida Nurse Workforce Projections - 2035
Understanding Your Hospital Bill
Guidance Documents
Medicare 101 Manual
Compliance Standards Manual
Florida HIPAA Preemption Analysis
News
About Us
Our Team
Board of Trustees
Member Directory
View the 2023 Directory of Florida Hospitals published by Naylor
Advocacy
State Advocacy
Federal Advocacy
>
Letters
FHA Political Committee
Health Care Issues
Behavioral Health
Workforce
>
Workforce Resources
Patients Awaiting Discharge to Post-Acute Care Settings
Emergency Management
Accreditation
Compliance/HIPAA
Hospital Finances
Quality & Safety
Education & Events
Annual Meeting
Hospital Days
Calendar
Popular Education Series
>
Novice Infection Prevention Series
Statewide Readmissions Prevention Series
Sponsor Opportunities
Reports & Resources
Economic Impact
Facts and Stats
Florida Nurse Workforce Projections - 2035
Understanding Your Hospital Bill
Guidance Documents
Medicare 101 Manual
Compliance Standards Manual
Florida HIPAA Preemption Analysis
News
About Us
Our Team
Board of Trustees
Member Directory
View the 2023 Directory of Florida Hospitals published by Naylor
Important Updates Regarding Nurses Licensed Outside of Florida
Important Updates Regarding the Direct Order and Reporting Process for Monoclonal Antibodies
Important Updates Regarding the FDA Emergency Use Authorization for Monoclonal Antibody Cocktail - Casirivimab and Imdevimab
Expanded Emergency Declaration Under 49 CFR § 390.23 No. 2020-002 (Relating to COVID-19)
